Loomis, Sayles & Company
NUS icon

Loomis, Sayles & Company’s Nu Skin NUS Stock Holding History

Loomis, Sayles & Company’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-178
Closed -$10K – 918
2021
Q2 		$10K Sell
178
-95
-35% -$5.41K ﹤0.01% 777
2021
Q1 		$14K Buy
+273
New +$14.9K ﹤0.01% 706
2018
Q1 		– Sell
-432
Closed -$29K – 910
2017
Q4 		$29K Hold
432
– – ﹤0.01% 706
2017
Q3 		$27K Sell
432
-15
-3% -$921 ﹤0.01% 711
2017
Q2 		$28K Buy
447
+28
+7% +$1.6K ﹤0.01% 707
2017
Q1 		$23K Buy
419
+53
+14% +$2.73K ﹤0.01% 760
2016
Q4 		$17K Buy
+366
New +$20.5K ﹤0.01% 802

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company's NUS Position: Q3 2021 in Review

Loomis, Sayles & Company sold out of Nu Skin (NUS) in Q3 2021, closing a stake of 178 shares — an estimated $10K sold.

Loomis, Sayles & Company first reported a position in NUS in Q4 2016 and held it in 7 quarters. The position peaked at $29K in Q4 2017. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

  • Loomis, Sayles & Company reported no remaining Nu Skin position as of Q3 2021 after selling out during the quarter.
  • Loomis, Sayles & Company sold 178 Nu Skin shares in Q3 2021, an estimated $10K.
  • Loomis, Sayles & Company first reported a position in Nu Skin in Q4 2016 and held it in 7 quarters.
  • Loomis, Sayles & Company's Nu Skin position peaked at $29K in Q4 2017.
  • 246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on Loomis, Sayles & Company's 13F filing for Q3 2021, filed 12 Nov 2021.